The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astrocytoma (NCT03528642).
 
Sani Haider Kizilbash
Research Funding - CBT Pharmaceuticals (Inst); DelMar Pharmaceuticals (Inst); Orbus Therapeutics (Inst)
 
Samuel McBrayer
Consulting or Advisory Role - Agios
 
John Port
No Relationships to Disclose
 
Joel M. Reid
Consulting or Advisory Role - BioMedical Systems (Inst); Neuronetics (Inst)
 
Ian Lanza
No Relationships to Disclose
 
Jacob B Allred
No Relationships to Disclose
 
Arnab Chakravarti
No Relationships to Disclose
 
Charles Kunos
No Relationships to Disclose
 
Alex A. Adjei
Research Funding - Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst)